Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 5/20 | 0.49 |
| ▸ | KCNK9 | Q9NPC2 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1359693 | 0.85 | ENPP2 (0.53) | KCNK3KCNK9RAB9ANPC1NLRP3 | |
| SCHEMBL27886604 | 0.85 | TSHR (0.39) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL1361514 | 0.79 | KMT2A (0.56) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL13875615 | 0.78 | KCNK3 (0.50) | KCNK3KCNK9RAB9AKMT2AMEN1 | |
| SCHEMBL2684118 | 0.77 | KCNK3 (0.69) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL12570375 | 0.74 | KCNK3 (0.59) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL29409938 | 0.74 | KCNK3 (0.59) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL16863615 | 0.74 | KCNK3 (0.55) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL2103913 | 0.74 | KCNK3 (0.57) | KCNK3KCNK9RAB9ANPC1KMT2A | |
| SCHEMBL13875614 | 0.73 | KMT2A (0.51) | KCNK3KCNK9RAB9ANPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067638-B2 | Amide derivative and insecticide containing the same | MITSUI CHEMICALS, INC. (JP) | 2011-11-29 | — | — | US | disclosed |
| US-20090233962-A1 | Amide derivative and insecticide containing the same | MITSUI CHEMICALS, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| CN-101203484-A | Amide derivative and pesticide containing such compound | MITSUI CHEMICALS INC (JP) | 2008-06-18 | — | — | CN | disclosed |
| EP-1911751-A1 | AMIDE DERIVATIVE AND PESTICIDE CONTAINING SUCH COMPOUND | Mitsui Chemicals, Inc. (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233962-A1 | Amide derivative and insecticide containing the same | CYP1A1, CYP4B1, CYP2E1 | KCNK3 910/4885KCNK9 1783/4885RAB9A 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.